Fangying Lu

1.1k total citations
17 papers, 145 citations indexed

About

Fangying Lu is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Fangying Lu has authored 17 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Fangying Lu's work include COVID-19 Clinical Research Studies (4 papers), Spine and Intervertebral Disc Pathology (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Fangying Lu is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Spine and Intervertebral Disc Pathology (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Fangying Lu collaborates with scholars based in China. Fangying Lu's co-authors include Rui He, Jing Shen, Weiping Jia, Qiang Wu, Yi Guo, Hongwei Yu, Huijuan Lu, Rong Chen, Hui Zeng and Ning Li and has published in prestigious journals such as Frontiers in Pharmacology, Diabetic Medicine and Public Health Nutrition.

In The Last Decade

Fangying Lu

13 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangying Lu China 7 53 28 28 27 25 17 145
Sema Hepşen Türkiye 11 40 0.8× 29 1.0× 9 0.3× 9 0.3× 13 0.5× 52 326
Shohei Mori Japan 8 47 0.9× 17 0.6× 87 3.1× 13 0.5× 42 1.7× 21 185
Imran Paruk South Africa 9 18 0.3× 51 1.8× 11 0.4× 8 0.3× 15 0.6× 17 219
Marion Venot France 6 11 0.2× 27 1.0× 24 0.9× 4 0.1× 25 1.0× 10 230
Blaž Krhin Slovenia 10 38 0.7× 33 1.2× 7 0.3× 4 0.1× 11 0.4× 16 327
Stephanie Dufek United Kingdom 7 36 0.7× 24 0.9× 68 2.4× 2 0.1× 24 1.0× 17 190
Mustafa Yenerçağ Türkiye 9 9 0.2× 12 0.4× 31 1.1× 4 0.1× 7 0.3× 41 204
Nesim Aladağ Türkiye 7 9 0.2× 24 0.9× 11 0.4× 2 0.1× 51 2.0× 21 175
Lasse Ramsgaard United States 8 20 0.4× 57 2.0× 183 6.5× 4 0.1× 4 0.2× 8 339
Manuel Barrera Spain 7 8 0.2× 21 0.8× 14 0.5× 4 0.1× 27 1.1× 28 185

Countries citing papers authored by Fangying Lu

Since Specialization
Citations

This map shows the geographic impact of Fangying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangying Lu more than expected).

Fields of papers citing papers by Fangying Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangying Lu. The network helps show where Fangying Lu may publish in the future.

Co-authorship network of co-authors of Fangying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangying Lu. A scholar is included among the top collaborators of Fangying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangying Lu. Fangying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jiangjie, et al.. (2024). Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis. Journal of bone oncology. 45. 100595–100595.
2.
Chen, Jiangjie, Fangying Lu, Bo Shen, et al.. (2024). Associations between pre-infection serum vitamin D concentrations and Omicron COVID-19 incidence, severity and reoccurrence in elderly individuals. Public Health Nutrition. 27(1). e197–e197. 3 indexed citations
3.
Huang, Weixing, Zhiyan Li, Wei Wang, et al.. (2024). Transcriptome Analysis of Differentially Expressed Genes and Molecular Pathways Involved in C2C12 Cells Myogenic Differentiation. Molecular Biotechnology. 67(9). 3640–3655.
4.
Sun, Jiacheng, et al.. (2023). AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption. Drug Design Development and Therapy. Volume 17. 1275–1288. 3 indexed citations
5.
Gong, Yuhang, Ting Jiang, Fangying Lu, et al.. (2023). Limonin delays the progression of intervertebral disc degeneration in vivo and in vitro: the key role of the MAPK/NF-κB and necroptosis pathways. Journal of Pharmacy and Pharmacology. 75(5). 612–624. 3 indexed citations
6.
Lu, Fangying, Rong Chen, Jie Huang, et al.. (2023). Liver dysfunction on admission worsens clinical manifestations and outcomes of coronavirus disease 2019. PubMed. 1(3). 181–187. 2 indexed citations
7.
Lu, Fangying, et al.. (2023). Knowledge, attitude, and practice regarding sarcopenia: a survey between orthopedic and geriatric professionals in China. Aging Clinical and Experimental Research. 35(10). 2019–2028. 6 indexed citations
8.
Xu, Cheng, Xinhui Wu, Fangying Lu, et al.. (2023). EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption. Clinical & Experimental Metastasis. 40(4). 357–371. 6 indexed citations
10.
Zhang, Weikang, Yuhang Gong, Ting Jiang, et al.. (2022). VX-11e protects articular cartilage and subchondral bone in osteoarthritis by inhibiting the RIP1/RIP3/MLKL and MAPK signaling pathways. Bioorganic Chemistry. 120. 105632–105632. 9 indexed citations
11.
Zhang, Weikang, Yuhang Gong, Jianxin Qiu, et al.. (2022). Platelet-Derived Growth Factor-BB Inhibits Intervertebral Disc Degeneration via Suppressing Pyroptosis and Activating the MAPK Signaling Pathway. Frontiers in Pharmacology. 12. 799130–799130. 19 indexed citations
12.
Lu, Fangying, et al.. (2022). Is spinal sagittal alignment of diffuse idiopathic skeletal hyperostosis relevant to thoracolumbar pain? A controlled study. BMC Musculoskeletal Disorders. 23(1). 1134–1134.
13.
Lu, Fangying, et al.. (2021). Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators. International Journal of COPD. Volume 16. 341–349. 26 indexed citations
14.
Chen, Rong, Fangying Lu, Bing Liu, et al.. (2021). Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib. Cancer Management and Research. Volume 13. 3619–3627. 5 indexed citations
15.
Guo, Lingxi, Weining Xiong, Dong Liu, et al.. (2020). <p>The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission</p>. Infection and Drug Resistance. Volume 13. 3593–3600. 4 indexed citations
16.
Lu, Fangying, Xiaoyan Jin, Rong Chen, et al.. (2020). Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics: A retrospective and multicenter study in China. Journal of Diabetes. 12(12). 919–928. 8 indexed citations
17.
He, Rui, Jing Shen, Hui Zeng, et al.. (2014). Vitamin D deficiency increases the risk of retinopathy in Chinese patients with Type 2 diabetes. Diabetic Medicine. 31(12). 1657–1664. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026